Virtual Reality to Combat Weight-Based Implicit Bias: BWH Pilot Study
Public ClinicalTrials.gov record NCT07283523. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Use of Virtual Reality to Combat Weight-Based Implicit Bias Among Physicians in Training at Brigham and Women's Hospital: A Pilot Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this pilot implementation study is to evaluate the impact of a virtual reality (VR) intervention on implicit bias for resident physicians. The main question it aims to answer are: Does watching VR experience of two clinical encounters reduce implicit bias association test scores? Is the VR experience an acceptable intervention tool for reducing implicit bias? Researchers will compare weight-based VR experiences consisting of two observed clinical encounters to a neutral education VR encounter to see if our intervention significantly impacts implicit bias association scores. Participants will be asked 1. Complete Implicit Association test for weight-based bias pre-intervention and post-intervention (immediately, at one week, and one month after the intervention) to assess their implicit bias 2. Watch either experimental clinical encounter videos or neutral education video using a VR headset 3. Participants will also complete an abbreviated IAT related to views on compliance
Study identification
- NCT ID
- NCT07283523
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 52 participants
Conditions and interventions
Conditions
Interventions
- 360 Video on a Virtual Reality Headset Behavioral
- 360-Control Video Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 18, 2024
- Primary completion
- Nov 29, 2026
- Completion
- Dec 30, 2026
- Last update posted
- Dec 15, 2025
2024 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07283523, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 15, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07283523 live on ClinicalTrials.gov.